chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8 hours after receiving the vaccine I developed chills, fever, headache, and stomach pain. This lasted until 2 pm the next day which would be 01/03/2022. I stayed hydrated and took Tylenol and got plenty of sleep. I also had fatigue and not much of an appetite. I finally broke my fever around 2 pm on 01/03/2022 and started feeling better but at 7 pm or so my chills, headache, and fever came back. My fever broke the morning of 01/04/2022 and as I am drafting this at 2:45 pm it hasn't came back. However, I still have a slight headache and fatigue.
Individual who is a teacher complained of arm tingling, redness from injection site to fingers and itchy. Person began experiencing throat/chest tightness. Epinephrine injection administered by the school nurse and then transported via EMS.
got my Shingrix shot too soon, before 2 months; This case was reported by a consumer via (ShingrixChatbot) interactive digital media and described the occurrence of drug dose administration interval too short in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got Shingrix shot too soon, before 2 months, earlier than the recommended interval, which led to shortening of vaccination schedule. The patient asked question, would it still be effective. The patient stated his/her pharmacist has not been able to give an answer. The follow-up would not possible as no contact details were available.
TOOK FIRST DOSE AND FORGOT TO TAKE OTHER DOSES; This spontaneous case (PVX2019-1402) report was received from a pharmacist on 31-May-2019. It describes a male consumer who "took first dose and forgot to take other doses". She was receiving Vivotif for an unknown indication.  Case report: The consumer took the first dose of Vivotif on 26-May-2019 and then, forgot to take other doses.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took first dose and forgot to take other doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took first dose and forgot to take other doses" was considered as not applicable.
Stabbing pain at injection site 20 minutes after injection.  Stabbing, Aching and Throbbing pain intermittently since injection. I believe it was injected in the wrong area of the arm. Either the nerve, or tendon.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received SHINGRIX. On 1st February 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 2nd February 2018, 1 days after receiving SHINGRIX, the patient experienced injection site pain, injection site erythema, injection site swelling, fever, fatigue and headache. In February 2018, the patient experienced myalgia. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling, myalgia and fever were not recovered/not resolved and the outcome of the fatigue and headache were unknown. It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, myalgia, fever, fatigue and headache to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Reporter was inquiring on behalf of his wife (patient). The patient received her first injection in a series of two for the SHINGRIX vaccine yesterday in her HCP's office. On 2nd February 2018, the patient woke up in the morning with complaints of pain, redness and swelling at the injection site, fatigue, headache and low grade fever. Less than a week after vaccination, the patient experienced myalgia. The reporter was inquiring whether she can take TYLENOL for her symptoms or if we recommend anything else. Informed the caller we could not provide medical advice and advised the caller to contact the doctor's office where the vaccine was administered.
can barely walk/dragging their feet; slowly getting reactions; covid-19; This spontaneous case was reported by a patient and describes the occurrence of GAIT DISTURBANCE (can barely walk/dragging their feet), IMMUNISATION REACTION (slowly getting reactions) and COVID-19 (covid-19) in an 80-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7145B) for COVID-19 prophylaxis.     Patient was in good health.  The patient's past medical history included Sneezing. Concurrent medical conditions included Thyroid disorder (Patient had thyroid and was taking medication for it.) and Seasonal allergy (Patient was allergic in the beginning of the summer and they start sneezing).    On 12-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2022, the patient experienced COVID-19 (covid-19). On an unknown date, the patient experienced GAIT DISTURBANCE (can barely walk/dragging their feet) and IMMUNISATION REACTION (slowly getting reactions). At the time of the report, GAIT DISTURBANCE (can barely walk/dragging their feet) and IMMUNISATION REACTION (slowly getting reactions) had not resolved and COVID-19 (covid-19) outcome was unknown.            Concomitant product included unspecified medication for thyroid.  It was reported that patient had Moderna vaccination for Covid 2 years ago and slowly getting reactions and at the time of reporting patient could barely walk. Patient was having trouble walking. Patient got the vaccine 2 years ago and it was affecting their walking. Patient was dragging, had no numbness, just dragging her feet. Patient went to the hospital to check and see if she had Parkinson and she did not. Patient got covid 1 year go.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-749084, US-MODERNATX, INC.-MOD-2023-749085. This case was linked to MOD-2023-749084, MOD-2023-749085.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-749084:Spikevax NOS case US-MODERNATX, INC.-MOD-2023-749085:Bivalent case
Rec'd PREVNAR 12-18-14. 12-19-14 came to appt. Mild swelling, tenderness, mild redness.
Pt received smallpox vaccine approximately 6/19/15. Came to clinic 7/4/15 with ulcerated area, redness itching to left deltoid at injection site. Pt was treated with KEFLEX 500mg 1 tab 3 times a day for 10 days.
At 10:30 PM on the day of the vaccine I became achy throughout my body, chills, headache and severe nausea.  By midnight my body was going in to full body cramping and nausea was unbearable along with the headache. Taken to emergency room at midnight.  all symptoms persisted through Sunday April 11th along with a fever up to 101.2 on the 10th.  By the 12th of April I was able to get up and move around and start to eat.  Today is the 18th and I continue to have bouts of nausea, poor appetite, intermittent body aches and tiredness.
Maximum conductive hearing loss on the left ear. Dislocation of stapes implanted in left ear in 2003. Since then constant noises in the ear. Viral infections through the whole body particularly in GI system.
broke out in hives all over her body; Warm; injection site was itchy; arm was red; arm was sore; felt like she had a bug bite; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), ARTHROPOD BITE (felt like she had a bug bite), URTICARIA (broke out in hives all over her body), FEELING HOT (Warm) and VACCINATION SITE PRURITUS (injection site was itchy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No reported medical history.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), ATORVASTATIN CALCIUM (LIPITOR) and DENOSUMAB (PROLIA) for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 24-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was sore), ARTHROPOD BITE (felt like she had a bug bite), FEELING HOT (Warm), VACCINATION SITE PRURITUS (injection site was itchy) and ERYTHEMA (arm was red). On 02-Feb-2021, the patient experienced URTICARIA (broke out in hives all over her body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL CHILDRENS) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm was sore), VACCINATION SITE PRURITUS (injection site was itchy) and ERYTHEMA (arm was red) had resolved, ARTHROPOD BITE (felt like she had a bug bite) and FEELING HOT (Warm) outcome was unknown and URTICARIA (broke out in hives all over her body) had not resolved. Not Provided
pt recv vax 11SEP97 & lab eval on 21NOV97 revealed a lack of seroconversion;
A report was received from a health care professional on 11/14/03, concerning a 56 year old female vaccinee who inadvertently received expired Fluvirin SC on 11/10/03. On 11/10/03, the vaccinee inadvertently received expired Fluvirin SC. The vaccinee had not experienced any adverse event at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
From initial information received on 3/30/04 from a physicians office regarding an adverse event occurring in the USA, it was reported that a 25 year old female patient received IMOVAX RABIES, lot number X0581-2, administration information not reported; and JE-VAX, lot number EJN205B, administered in the left arm, on 3/30/04. Three hours later the patient complained of mild numbness, tingling, and soreness in her left hand, arm and shoulder; and tingling in the right side of her face. The patient did seek medical attention, however, details were not provided. The patient's recovery status was not reported. From additional correspondence received on 5/10/04 from the initial reporter, no further information could be provided. Further information is not anticipated, this case is considered closed.
The next day i began to feel eye irritation. Ive been having eye irritation ever since ( pink eye) no discharge just inflammation and irritation.  It has not gone away ive been using antihistamine eye drops but it has not been improving . I had gone to urgent care and was told it was allergies and was subcribed antihistamine but ive never had allergies or pink eye before.
Flu shot & Pfizer booster  same day Weakness within 2 hours -- continues to current  date.  PIns & needles sensation by bedtime.  Pain (not pins & needles) lasted to current date. Sweeling feet & ankles  == both sides.
Frequent and persistent headaches starting date of second injection and continuing through today.  I have tried OTC painkillers, seeing my primary care provider and chiropractic care and have had no relief.
Aching; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 16Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset Aug2021, outcome "unknown", described as "Aching".  Additional information: The patient will have dental appointment after 2 days. Dental appointment and it was like for the paining and, but the patient was given the premedication antibiotic Amoxicillin so they wanted to ask if this will have any issues with the Pfizer vaccine. It was given to the patient as a pre medication but not has been taken yet. The reporter wanted to know if it's gonna be okay with the vaccine since the dental appointment would be 18Aug2021 and Amoxicillin should be taken before that dental appointment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Case number PHEH2014US018218 is an initial spontaneous report from the health care professional (medical assistant) received on 08 Sep 2014. This report refers to a 17-year-old female patient. She was vaccinated with MENVEO (batch number: not reported) at a dose of 0.5 ml intramuscularly on 29 Aug 2014. It was reported that the vaccine received by the patient had been stored at 47 F for 10 minutes before administration to the patient. No adverse event reported following this medication error (incorrect storage of drug).
SAME SYMPTOMS AS WHEN HAD COVID; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced same symptoms as when had covid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of same symptoms as when had covid was not reported. This report was non-serious.
Information has been received from a physician concerning an "18 year old" female who on 18-MAY-2007 who on 18-MAY-2007 was vaccinated IM in her left arm with Gardasil. Concomitant therapy included VAQTA and BOOSTRIX. On 19-MAY-2007 the patient experienced severe lower right abdominal pain. The patient sought medical attention at the hospital and had a CT Scan performed. It was reported the CT Scan was normal and the patient was not admitted to the hospital. Subsequently, the patient recovered from severe lower right abdominal pain. Additional information has been requested.
Fatigue up to a week after Covid 2nd shot; This is a spontaneous report from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Apr2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included diet-controlled diabetes mellitus (DM). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 08:00, after COVID 2nd shot, the patient experienced fatigue up to a week. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with acupuncture. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fatigue up to a week after Covid 2nd shot was resolved with sequelae on an unknown date in May2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Pt reported redness, swole , sore, ?hurts to touch? at injection site
Patient stated that she got shingle in her neck/right ear; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Patient stated that she got shingle in her neck/right ear) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced HERPES ZOSTER (Patient stated that she got shingle in her neck/right ear). The patient was treated with ACYCLOVIR [ACICLOVIR] at a dose of 800 mg. At the time of the report, HERPES ZOSTER (Patient stated that she got shingle in her neck/right ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported
dose one years ago, dose two months ago; This case was reported by a pharmacist and described the occurrence of drug dose administration interval too long in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number PK5B921, expiry date 15th November 2021) for prophylaxis.   Previously administered products included Shingrix (1st dose received 3 years ago).   On 24th June 2021, the patient received the 2nd dose of Shingrix. On 24th June 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided are as follows: The patient received 2nd dose of Shingrix (a few months ago) later than the recommended interval, which led to lengthening of vaccination schedule. The reporter did not had administration date, lot number or expiration date for 1st dose of Shingrix. The reporter consented to follow-up.
False positive mammogram, biopsy revealed normal lymph node. Recovery from biopsy took about two months. Unnecessary procedure probably caused by Covid vaccine.  No prior abmornal mammograms.
When I take vaccine most the time I was sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  An adult female patient received PF-06928316 (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "When I take vaccine most the time I was sick".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
In September 2021, I started growing cyst in my left knee, ankle, neck, left elbow, right knee, second joints in my fingers, and the back of my neck. I have gotten cortisone shots, fluid removed from the knee. Cyst have grown larger and multiplied after third dose of the vaccine.
Pt recv vax on 10/26/98; on 10/28/98 pt exp edematous rt arm w/ erythema; dx=cellulitis; tx=Keflex
Left arm-elbow to shoulder sore for 4 days. No swelling. Arm "thick". Went to Dr for U/S and X-ray. After 2 months still achy and tingling down to hand while at rest. Cannot lift arm above head. No heat, no swelling. No redness. Went to Ortho MD 1 wk ago. No treatment for dull, ache. Told patient to give it 6 months to get better, and to call him if it gets worse. Difficulty lifting arm. Dull ache.
Several months later after the second dose, hair was falling out of the top of his forearms/hair falling out of the back of his hands/hair falling off of legs.; muscle aches; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Several months later after the second dose, hair was falling out of the top of his forearms/hair falling out of the back of his hands/hair falling off of legs.), MYALGIA (muscle aches) and VACCINATION SITE PAIN (soreness at the injection site) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (muscle aches) and VACCINATION SITE PAIN (soreness at the injection site). In September 2021, the patient experienced ALOPECIA (Several months later after the second dose, hair was falling out of the top of his forearms/hair falling out of the back of his hands/hair falling off of legs.). At the time of the report, ALOPECIA (Several months later after the second dose, hair was falling out of the top of his forearms/hair falling out of the back of his hands/hair falling off of legs.), MYALGIA (muscle aches) and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.            No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2022-445521 (Patient Link).
Vaccines were stored in the fridge on 30Jun2021 and administered on 04-Aug-2021; No adverse event; 40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored), PRODUCT STORAGE ERROR (Vaccines were stored in the fridge on 30Jun2021 and administered on 04-Aug-2021) and NO ADVERSE EVENT (No adverse event) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 04-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines were stored in the fridge on 30Jun2021 and administered on 04-Aug-2021) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored), PRODUCT STORAGE ERROR (Vaccines were stored in the fridge on 30Jun2021 and administered on 04-Aug-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (40 patients received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored) and PRODUCT STORAGE ERROR (Vaccines were stored in the fridge on 30Jun2021 and administered on 04-Aug-2021).    No concomitant and treatment medications were reported.  Reported that 40 patients received the Moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge. Vaccines were stored in the fridge on 30Jun2021, there are different administration dates, starting on 02Aug2021 until 20Sep2021 being the last one. Patients did not report any side effects.   This case reported for patient 5 of 31 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-698994 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-698994:Master case ID